BETAPLUS – a comprehensive patient support program


 

BETAPLUS aims to encourage adherence in patients taking BETAFERON.

 

Adherence to medication is critical to ensure the effectiveness of healthcare [1]. Unfortunately, poor adherence to therapeutic regimens is widespread among patients with MS [1,2]. Evidence suggests that mode of administration is not a barrier to adherence [2-4]; instead, supportive strategies can have a strong influence [2,5]. Shared effort, a multi-disciplinary team approach and patient support programs have been shown to positively influence adherence [2,6-9].

 

BETAFERON’s patient support program BETAPLUS offers a variety of services to help promote adherence, including:

 

  • BETA nurses: nursing professionals specially trained to support MS patients taking BETAFERON throughout their entire treatment journey
  • Patient information materials such as training leaflets or videos
  • Modern autoinjectors including BETACONNECT

 

Patient services and their features may vary from country to country. Please contact your local Bayer affiliation for more details. 

 

References

  • World Health Organization. Adherence to long-term therapies. Available at: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1 (accessed March 19, 2020). Return to content
  • Lugaresi A et al. Expert Rev Neurother 2014; 14(9): 1029-42. Return to content
  • Longbrake EE et al. Mult Scler J Exp Transl Clin 2016; 2: 2055217316677868. Return to content
  • Burks J et al. Clinicoecon Outcomes Res Actions 2017; 9: 251-60. Return to content
  • Sejbaek T et al. Mult Scler Rel Disord 2018; 24: 42-6. Return to content
  • Tan H et al. Mult Scler 2010; 16: 956-63. Return to content
  • Tan H et al. Adv Ther 2011; 28(1): 51-61. Return to content
  • Stockl KM et al. Am J Manag Care 2010; 16: 139-44. Return to content
  • DuChane J et al. J MS Care 2015; 17: 57-64. Return to content
Alt tag